These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8492135)

  • 1. In vivo imaging of vesicular monoamine transporters in human brain using [11C]tetrabenazine and positron emission tomography.
    Kilbourn MR; DaSilva JN; Frey KA; Koeppe RA; Kuhl DE
    J Neurochem; 1993 Jun; 60(6):2315-8. PubMed ID: 8492135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of extrastriatal vesicular monoamine transporter binding site density using stereoisomers of [11C]dihydrotetrabenazine.
    Koeppe RA; Frey KA; Kuhl DE; Kilbourn MR
    J Cereb Blood Flow Metab; 1999 Dec; 19(12):1376-84. PubMed ID: 10598942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo imaging of the brain vesicular monoamine transporter.
    Vander Borght TM; Kilbourn MR; Koeppe RA; DaSilva JN; Carey JE; Kuhl DE; Frey KA
    J Nucl Med; 1995 Dec; 36(12):2252-60. PubMed ID: 8523116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo binding of [11C]tetrabenazine to vesicular monoamine transporters in mouse brain.
    DaSilva JN; Kilbourn MR
    Life Sci; 1992; 51(8):593-600. PubMed ID: 1640810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of dopaminergic drug treatments on in vivo radioligand binding to brain vesicular monoamine transporters.
    Kilbourn MR; Frey KA; Vander Borght T; Sherman PS
    Nucl Med Biol; 1996 May; 23(4):467-71. PubMed ID: 8832701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging of monoaminergic and cholinergic vesicular transporters in the brain.
    Frey KA; Wieland DM; Kilbourn MR
    Adv Pharmacol; 1998; 42():269-72. PubMed ID: 9327896
    [No Abstract]   [Full Text] [Related]  

  • 7. Synthesis of a [11C]methoxy derivative of alpha-dihydrotetrabenazine: a radioligand for studying the vesicular monoamine transporter.
    DaSilva JN; Kilbourn MR; Mangner TJ
    Appl Radiat Isot; 1993 Dec; 44(12):1487-9. PubMed ID: 7903060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of alpha-dihydrotetrabenazine to the vesicular monoamine transporter is stereospecific.
    Kilbourn M; Lee L; Vander Borght T; Jewett D; Frey K
    Eur J Pharmacol; 1995 May; 278(3):249-52. PubMed ID: 7589162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amino- and amido-tetrabenazine derivatives: synthesis and evaluation as potential ligands for the vesicular monoamine transporter.
    Canney DJ; Kung MP; Kung HF
    Nucl Med Biol; 1995 May; 22(4):527-35. PubMed ID: 7550031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of [11C]tetrabenazine as an in vivo radioligand for the vesicular monoamine transporter.
    DaSilva JN; Carey JE; Sherman PS; Pisani TJ; Kilbourn MR
    Nucl Med Biol; 1994 Feb; 21(2):151-6. PubMed ID: 9234277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid and differential losses of in vivo dopamine transporter (DAT) and vesicular monoamine transporter (VMAT2) radioligand binding in MPTP-treated mice.
    Kilbourn MR; Kuszpit K; Sherman P
    Synapse; 2000 Mar; 35(4):250-5. PubMed ID: 10657034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutant mouse strains as models for in vivo radiotracer evaluations: [11C]methoxytetrabenazine ([11C]MTBZ) in tottering mice.
    Kilbourn MR; Sherman PS; Abbott LC
    Nucl Med Biol; 1995 Jul; 22(5):565-7. PubMed ID: 7581164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased ventral striatal monoaminergic innervation in Tourette syndrome.
    Albin RL; Koeppe RA; Bohnen NI; Nichols TE; Meyer P; Wernette K; Minoshima S; Kilbourn MR; Frey KA
    Neurology; 2003 Aug; 61(3):310-5. PubMed ID: 12913189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo imaging of monoaminergic nerve terminals in normal and MPTP-lesioned primate brain using positron emission tomography (PET) and [11C]tetrabenazine.
    DaSilva JN; Kilbourn MR; Domino EF
    Synapse; 1993 Jun; 14(2):128-31. PubMed ID: 8332945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo studies of benzisoquinoline ligands for the brain synaptic vesicle monoamine transporter.
    Lee LC; Vander Borght T; Sherman PS; Frey KA; Kilbourn MR
    J Med Chem; 1996 Jan; 39(1):191-6. PubMed ID: 8568807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Striatal concentrations of vesicular monoamine transporters are identical in MPTP-sensitive (C57BL/6) and -insensitive (CD-1) mouse strains.
    Kilbourn M; Frey K
    Eur J Pharmacol; 1996 Jun; 307(2):227-32. PubMed ID: 8832225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PET study of [11C]beta-CIT binding to monoamine transporters in the monkey and human brain.
    Farde L; Halldin C; Müller L; Suhara T; Karlsson P; Hall H
    Synapse; 1994 Feb; 16(2):93-103. PubMed ID: 8197578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Equilibrium versus compartmental analysis for assessment of the vesicular monoamine transporter using (+)-alpha-[11C]dihydrotetrabenazine (DTBZ) and positron emission tomography.
    Koeppe RA; Frey KA; Kume A; Albin R; Kilbourn MR; Kuhl DE
    J Cereb Blood Flow Metab; 1997 Sep; 17(9):919-31. PubMed ID: 9307605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetic evaluation of [11C]dihydrotetrabenazine by dynamic PET: measurement of vesicular monoamine transporter.
    Koeppe RA; Frey KA; Vander Borght TM; Karlamangla A; Jewett DM; Lee LC; Kilbourn MR; Kuhl DE
    J Cereb Blood Flow Metab; 1996 Nov; 16(6):1288-99. PubMed ID: 8898703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presynaptic monoaminergic vesicles in Parkinson's disease and normal aging.
    Frey KA; Koeppe RA; Kilbourn MR; Vander Borght TM; Albin RL; Gilman S; Kuhl DE
    Ann Neurol; 1996 Dec; 40(6):873-84. PubMed ID: 9007092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.